1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 0,620 | 0,673 | 12:13 |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| THERACLION Aktie jetzt für 0€ handeln | |||||
| 16.09. | 2026 Half-Year Results: Theraclion Prepares for a New Stage in Its Development | 515 | Business Wire | Regulatory News:
THERACLION (ISIN: FR0010120402; Ticker: ALTHE), an innovative company developing Sonovein, a robotic platform for non-invasive treatment of varicose veins using High-Intensity... ► Artikel lesen | |
| 20.08. | Theraclion: Monthly Information on the Total Number of Voting Rights and Shares Comprising the Share Capital | 485 | Business Wire | Article 223-16 du Règlement Général de l'Autorité des marchés financiers
Regulatory News:
Theraclion (Paris:ALTHE):
Listed on Euronext Growth Paris
PEA PME eligible
ISIN Code: FR0010120402
Website:... ► Artikel lesen | |
| 23.07. | Theraclion Initiates Its Commercial Momentum in the First Half of 2026 | 614 | Business Wire | Regulatory News:
THERACLION (ISIN: FR0010120402; Ticker: ALTHE), an innovative company developing Sonovein, a robotic platform for non-invasive varicose vein therapy using High-Intensity Focused... ► Artikel lesen | |
| 15.07. | Theraclion: First Half 2026 Report on the Liquidity Contract With CRÉDIT INDUSTRIEL ET COMMERCIAL | 447 | Business Wire | Regulatory News:
Theraclion (Paris:ALTHE):
Listing venue: Euronext Growth Paris
PEA-PME eligible
ISIN Code: FR0010120402
Website: www.theraclion.com
Under the liquidity contract entrusted... ► Artikel lesen | |
| 09.07. | Theraclion Strengthens Its Governance by Appointing Vincent Gardès as Chairman of Its Board of Directors | 503 | Business Wire | Regulatory News:
THERACLION (ISIN: FR0010120402; Mnemo: ALTHE), an innovative company developing Sonovein, a robotic platform for non-invasive varicose vein therapy using High-Intensity Focused... ► Artikel lesen | |
| 02.07. | Theraclion: Monthly Information on the Total Number of Voting Rights and Shares Comprising the Share Capital | 430 | Business Wire | Article 223-16 Règlement Général de l'Autorité des marchés financiers
Regulatory News:
Theraclion (Paris:ALTHE):
Listed on Euronext Growth Paris
PEA PME eligible
ISIN Code: FR0010120402
Website:... ► Artikel lesen | |
| 18.06. | Theraclion Announces the Evolution of Its Board of Directors | 949 | Business Wire | Regulatory News:
THERACLION (ISIN: FR0010120402; Mnemo: ALTHE), an innovative company developing Sonovein, a robotic platform for non-invasive varicose vein therapy using High-Intensity Focused... ► Artikel lesen | |
| 08.06. | Theraclion Secures Key U.S. Reimbursement Milestone for Sonovein With AMA CPT Editorial Panel Approval of a New Category III CPT Code | 517 | Business Wire | Regulatory News:
Theraclion (ISIN: FR0010120402; Ticker: ALTHE), an innovative company developing a platform for non-invasive therapy using high intensity focused ultrasound (HIFU) for the treatment... ► Artikel lesen | |
| 04.06. | Theraclion Announces First Clinical Deployment of Sonovein in Hainan, China | 574 | Business Wire | Regulatory News:
THERACLION (ISIN: FR0010120402 Mnemo: ALTHE), an innovative company developing a robotic platform for non-invasive therapy using high intensity focused ultrasound (HIFU) for the... ► Artikel lesen | |
| 03.06. | Theraclion: Monthly Information on the Total Number of Voting Rights and Shares Comprising the Share Capital | 422 | Business Wire | Article 223-16 du Règlement Général de l'Autorité des marchés financiers
Regulatory News:
Theraclion (Paris:ALTHE):
Listed on Euronext Growth Paris
PEA PME eligible
ISIN Code: FR0010120402
Website:... ► Artikel lesen | |
| 01.06. | Theraclion Announces the Success of the First International HIFU Congress in Parma, Where Promising Preliminary Results From Its Sonovein SpeedPulse Were Presented | 470 | Business Wire | Regulatory News:
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260601718811/en/Illustration of Sonovein with new robotics SpeedPulse
Theraclion... ► Artikel lesen | |
| 11.05. | Theraclion Announces the Strong Success of Its Oversubscribed Capital Increase | 522 | Business Wire | Capital increase of a gross amount of 6 million Issue of 12,484,467 BSA enabling an additional fundraising of 2 million
Regulatory News:
This press release and the information it contains... ► Artikel lesen | |
| 28.04. | Theraclion's non-invasive varicose treatment poised for FDA decision | 2 | The Armchair Trader | ||
| 23.04. | XFRA NEW INSTRUMENTS AVAILABLE ON 23.04.2026 | 653 | Xetra Newsboard | The following instruments on XETRA do have their first trading 23.04.2026 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 23.04.2026
Aktien
1 ID1000132806 PT Multi Bintang Indonesia... ► Artikel lesen | |
| 20.04. | Theraclion Announces the Launch of a Capital Increase Through the Issuance of ABSA (Shares With Share Warrants Attached), With Preferential Subscription Rights for Existing Shareholders, for a Gross Amount of €6 Million, Secured by Subscription... | 889 | Business Wire | Subscription price: €0.48 per share, representing a nominal discount of 3.52% to the closing share price as of April 17, 2026, and a discount of 8.60% when taking into account the theoretical... ► Artikel lesen | |
| 16.04. | Theraclion Publishes Its 2025 Financial Results and Provides an Update on Its Outlook | 720 | Business Wire | Regulatory News:
THERACLION (ISIN: FR0010120402; Mnemo: ALTHE), an innovative company developing Sonovein, a robotic platform for non-invasive High-Intensity Focused Ultrasound (HIFU) varicose... ► Artikel lesen | |
| 29.01. | Theraclion Delivers a Structuring Year in 2025 and Prepares to Scale up | 556 | Business Wire | Regulatory News:
THERACLION (ISIN: FR0010120402; Mnemo: ALTHE), an innovative company developing Sonovein, a robotic platform for non-invasive High-Intensity Focused Ultrasound (HIFU) varicose... ► Artikel lesen | |
| 09.12.25 | Theraclion Announces Sonovein FDA Submission Following a Strong Year of Regulatory and Clinical Achievements | 843 | Business Wire | Regulatory News:
THERACLION (ISIN: FR0010120402; Mnemo: ALTHE), an innovative company developing Sonovein, a robotic platform for non-invasive High-Intensity Focused Ultrasound (HIFU) varicose... ► Artikel lesen | |
| 29.10.25 | Theraclion Reports Major Recent Developments and Announces Its 2025 Half-Year Financial Results | 666 | Business Wire | Regulatory News:
THERACLION (ISIN: FR0010120402; Mnemo: ALTHE), an innovative company developing Sonovein, a robotic platform for non-invasive High-Intensity Focused Ultrasound (HIFU) varicose... ► Artikel lesen | |
| 21.10.25 | Theraclion Secures Key Chinese Certification, Advancing Toward Market Access in China | 508 | Business Wire | Regulatory News:
THERACLION (ISIN: FR0010120402; Mnemo: ALTHE), an innovative company developing Sonovein®, a robotic platform for non-invasive High-Intensity Focused Ultrasound (HIFU) varicose... ► Artikel lesen |
1 2 Weiter >>
21 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| GERRESHEIMER | 28,800 | +1,48 % | Gerresheimer AG: Q2 zeigt eine Erholung, aber noch keine überzeugende Equity Story. VERKAUFEN | Die vorläufigen Ergebnisse von Gerresheimer für das zweite Quartal 2026 zeigen eine deutliche sequenzielle Erholung. Der Umsatz stieg auf 578 Mio. EUR, das bereinigte EBITDA auf 102 Mio. EUR, wodurch... ► Artikel lesen | |
| MCKESSON | 817,00 | -0,22 % | ROUNDUP/Aktien New York: Gewinne - S&P 500 und Nasdaq 100 mit Rekorden | NEW YORK (dpa-AFX) - Mit Gewinnen und Höchstständen der Leitindizes S&P 500 und Nasdaq 100 sind die US-Aktienmärkte am Dienstag in den Handel gestartet. Begründet wird die freundliche Tendenz mit einer... ► Artikel lesen | |
| INMODE | 12,630 | +1,77 % | InMode Ltd.: InMode Reports Second Quarter 2026 Financial Results: Quarterly GAAP Revenues of $95.6 Million, Consistent with the Second Quarter of 2025 | YOKNEAM, Israel, Aug. 5, 2026 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD) ("InMode"), a leading global provider of innovative medical technologies, today announced... ► Artikel lesen | |
| HCA HEALTHCARE | 386,30 | +0,65 % | Cantor Fitzgerald reiterates HCA Healthcare stock rating on stable labor | ||
| LIMES SCHLOSSKLINIKEN | 550,00 | +3,77 % | Aktien KW 36 Iran, Zinsangst und Trump-"unsinn" bremsen - was wäre wenn? News. Rheinmetall. Vonovia. DEFAMA. Smartbroker. Sino. Trade Republic. Limes Schlosskliniken. Mutares. Symrise. Aroundtown. Enapter. Bilfinger. Nagarro. Haier Smart. Delivery Hero | Aktien - diese Woche im Niemandsland. Positiv am Ende der Woche steht wieder 26 am Anafng des DAX, aber Schwung nach oben fehlt. Impulse hätten Nvidia und die anderen Ki-Aktien mit teilweise beeindruckenden... ► Artikel lesen | |
| BEYOND AIR | 2,550 | 0,00 % | Beyond Air Receives FDA Breakthrough Device Designation for LungFit GO to Treat Nontuberculous Mycobacterial Pulmonary Disease (NTM-PD) | GARDEN CITY, N.Y., Aug. 31, 2026 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR) ("Beyond Air" or the "Company"), a commercial-stage medical device and biopharmaceutical company focused on harnessing... ► Artikel lesen | |
| HEALTHCARE SERVICES GROUP | 18,500 | -1,07 % | HEALTHCARE SERVICES GROUP INC - S-8, Securities to be offered to employees in employee benefit plans | ||
| ADDUS HOMECARE | 99,50 | 0,00 % | Raymond James startet Coverage für Addus HomeCare mit "Outperform" | ||
| INTERPACE BIOSCIENCES | - | - | Interpace Biosciences, Inc.: Interpace Biosciences Announces Reverse Stock Split to Support Proposed Nasdaq Uplisting | PARSIPPANY, NJ, Aug. 26, 2026 (GLOBE NEWSWIRE) -- Interpace Biosciences, Inc. (OTCID: IDXG) ("Interpace" or the "Company"), an emerging leader in enabling personalized medicine, today announced that... ► Artikel lesen | |
| MYOMO | 1,542 | +9,21 % | Myomo Q2 2026 Earnings Call Transcript | ||
| MODERN DENTAL | 0,870 | 0,00 % | Dividendenbekanntmachungen (09.09.2026) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ALUMINUM CORPORATION OF CHINA LTD CNE1000001T8 0,319 HKD 0,0349 EUR ANHUI CONCH CEMENT CO LTD ADR US0352431045 0,0958 USD 0,0824... ► Artikel lesen | |
| IVF HARTMANN | 134,00 | 0,00 % | IVF Hartmann erwirtschaftet im Halbjahr klar mehr Umsatz | Neuhausen am Rheinfall - Der Medizinalbedarf-Hersteller IVF Hartmann hat im ersten Halbjahr 2026 den Umsatz zweistellig gesteigert. Der Gewinn nahm im Vergleich dazu noch deutlicher zu. Die Prognose... ► Artikel lesen | |
| ICU MEDICAL | 141,00 | 0,00 % | Biotech Stocks At 52-Week Highs - Anika Therapeutics & Chemed Corporation Rise With Q2 Results, ICU Medical, Neurocrine Biosciences, Royalty Pharma | LONDON (dpa-AFX) - The following biotech stocks reached a 52-week high on July 29, 2026, driven by key catalysts such as the release of second quarter financial results and ongoing clinical... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 63,75 | 0,00 % | BMO Capital reiterates Outperform on BrightSpring Health stock | ||
| HEARTFLOW | 50,70 | +0,02 % | Biotech Stocks At 52-Week Highs - Vaxcyte +31% On Phase 3 Results, InfuSystem, Illumina +7%, Charles River Laboratories +7%, HeartFlow +5% | SAN DIEGO (dpa-AFX) - The following biotech stocks reached a 52-week high on October 5, 2026, driven by key catalysts such as encouraging clinical research data.Vaxcyte Inc. (PCVX)Vaxcyte is... ► Artikel lesen |
Das Unternehmen THERACLION SA kann der Branche Gesundheitswesen zugeordnet werden. Die relative Kursveränderung beträgt aktuell 0,00 % bei einem Aktienkurs von 0,642 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu THERACLION SA finden Sie auf Wallstreet Online.